Introduction
Estimates of the occurrence of the immune reconstitution inflammatory syndrome (IRIS) in association with initiation or reinitiation of highly active antiretroviral therapy (HAART) to treat HIV infection vary widely. In patients presenting with known opportunistic infections, the rate may be as high as 45% whereas, with all patients placed on HAART, the rate may be 25%. 1, 2 We were interested in studying IRIS in a rural Ethiopian patient population where the syndrome appeared to be common and was associated with death in some patients. It is important to recognize IRIS because it is easily confused with new onset of an opportunistic infection and the treatment may be different.
Our experience in Ethiopia demonstrated that IRIS was a common cause for admission to the hospital of individuals treated with HAART. The majority of the HIV-infected patients admitted to the hospital prior to the administration of HAART were admitted for diagnosis and treatment of opportunistic infections. HIV-infected patients admitted to the hospital after the initiation of HAART were admitted most commonly for manifestations of IRIS associated with a previously often unrecognized opportunistic infection.
Methods

Clinic Facility
The HIV clinic was located in the Dessie Referral Hospital in Dessie, Ethiopia, a city of 169 000 people (in 2005) in northcentral Ethiopia. The majority of the clinic patients lived in impoverished rural settings. Some patients traveled over 200 miles to the clinic on foot (eg, many patients came from the Afar Region of Ethiopia). The clinic began providing care for patients with HIV in 2004 and by October 2006 had enrolled 3477 unique patients.
The clinic was staffed by 1 physician during the week along with 2 nurses who performed patient intakes and wrote prescriptions for HAART and other medications. The physician first evaluated patients upon their return for medication refill.
A laboratory on-site performed complete blood counts with differential, a metabolic panel with liver and renal function tests, CD4 counts and stool examinations. The CD4 count was determined once prior to the start of therapy. Patients with a CD4 count of less than 500 cells/mm 3 were placed on prophylactic cotrimoxazole. The HAART regimens included nevirapine (NVP) or efavirenz (EFV) in addition to zidovudine (ZDV) and lamivudine (3TC; as Combivir) or stavudine (d4T) and 3TC. These medications were used in accord with the established Ethiopian HAART guidelines 3 and second-line therapy was not available at the time of the study. This was a clinic funded by the US President's Emergency Plan for AIDS Relief (PRPFAR).
IRIS Definition
The hospitalized patient was considered to have IRIS on the basis of the following characteristics: (a) a positive HIV ELISA test; (b) a low initial CD4 count (usually < 100 cell/mm 3 ) before the initiation of HAART; (c) an inflammatory process that became manifest or worsened after beginning HAART; (d) in addition, the inflammatory process was not an anticipated response to the treatment of any identified opportunistic infection; and (e) an unwillingness to take HAART was not identified as a contributing factor to the inflammatory process. Viral loads were not available and hence could not be considered in the definition. This working diagnosis of IRIS incorporates aspects of Shelburne et al 1 and Robertson et al. 4 
Opportunistic Infections
Because of limited resources, opportunistic infections were identified in the following manner. Tuberculosis was diagnosed by demonstration of acid-fast bacilli in sputum or skin biopsy; or an abnormal chest X ray along with symptoms suggestive of tuberculosis; or pleural, joint or ascites fluid with a lymphocytic cellular predominance, elevated protein, and low glucose values. Patients coinfected with tuberculosis were treated for tuberculosis for 2 to 8 weeks before HAART was added according to protocol. 3 The same guideline does not recommend interrupting HAART when treating tuberculosis. 3 Pneumocystis jiroveci pneumonia (PCP) was diagnosed by chest X ray along with a compatible history and response to cotrimoxasole therapy; cryptococcal meningitis by compatible history and examination of cerebral spinal fluid with India ink; central nervous system toxoplasmosis by a compatible physical examination and evidence of central nervous system space occupying lesions usually with preservation of the mental status; and gastroenteritis was diagnosed when the patient was admitted with diarrhea, with or without nausea, vomiting, or fever. The symptoms of gastroenteritis were present for days to weeks and there was no evidence of blood in the stool. No bacterial, fungal, or mycobacterial cultures were available.
Records
The records of 3477 HIV-infected patients enrolled at the clinic were sampled for review as follows: From a total of 1078 patient records, 89 charts were sought from 2004 when the program began; 922 records were sought from patients seen over [2005] [2006] ; and the last 66 patient records sought were from October 2006. This was done to determine if the patients, patient problems, or the management of the clinic had substantially changed since the inception of the clinic in 2004. Seventy-six charts or 7% could not be found (16 of a possible 89 charts or 18% from the early patient group; 53 or 6% from the main patient group; and 7 or 10% from the last patient group). This appeared to indicate that, in part, losing a chart was a function of how long the patient was enrolled in the clinic. Of the 1002 patient charts reviewed, 226 or 22% of the patients were lost to follow-up (30 or 34% in the early group; 189 or 20% in the main group and 7 or 11% in the last patient group, indicating again, that the longer the patients were enrolled, the greater the loss to follow-up). Of 1002 patient charts present for review, 88 patients or 9% did not have a CD4 cell counts recorded.
Data Collection
Patient records were inspected for demographic and patient care data to include the start date of HAART, the regimen, the first CD4 count recorded, and the most recent clinic visit date. Data were abstracted from the charts and entered anonymously into an Excel program. Patients were considered lost to follow-up if there was no data entry for 60 days or more. By protocol, they were required to return to the pharmacy monthly and were issued only 1 month of HAART.
The protocol for data collection was approved by the hospital, waived by the sponsoring organization, and filed with the Institutional Ethics Review Committee of the Ethiopian Science and Technology Commission.
Results
General Patient Characteristics
The majority of the patients were women, 568 or 57%. There were 434 men, representing 43% of the selected patient population. The age range was identical for each sex, 34 + 8 years. The CD4 counts were very low, an average of 102 + 77 cells/mm 3 with a median CD4 count of 89 cells/mm 3 . The CD4 counts for the 3 patient-sample groups indicated that the patients came to medical attention earlier, the longer the clinic stayed in existence as reflected in the rise in median CD4 count. The median CD4 count was 74 cells/mm 3 in the early group of 2004, 88 cells/mm 3 in the main group, and 104 cells/mm 3 in the last patient group in 2006.
Hospitalization Prior to and After Initiation of HAART
Prior to starting HAART, 74 or 7% of the 1002 patients in the study were admitted to the hospital. Of these 74 HIV-positive patients not on antiretroviral therapy, 51 (5%) were admitted for an infectious disease-related problem and 23 (2%) were admitted for problems unrelated to infection. No patient died during hospitalization.
After the initiation of HAART, 98 or 10% of the patients were hospitalized. Seventy-four (or 7% of the total number of patient records reviewed) were hospitalized for complications of IRIS (Table 1) . Twenty-four patients were admitted for problems unrelated to IRIS, 18 for anemia related to the use of ZDV, and 6 for noninfectious causes such as neuropathy and edema.
Opportunistic Infections Associated with IRIS
Patients on HAART were admitted most often because of worsening symptoms relating to AIDS-defining opportunistic infections. Most of the infections (with the exception of 14 cases of tuberculosis) were unrecognized at the time the patients were placed on HAART.
Tuberculosis
Tuberculosis was the most common opportunistic infection with IRIS ( Table 1 ). The manifestations of tuberculosis leading to hospitalization in patients with IRIS were increased girth in patients with abdominal tuberculosis; increased pleural effusions in patients with pleural tuberculosis, and increased hemoptysis in patients with parenchymal pulmonary tuberculosis. Other manifestations of the disease included worsening skin and joint tuberculosis. Immune reconstitution inflammatory syndrome associated with tuberculosis was noted to occur from 2 to 90 days after the initiation of HAART (median, 30 days). Fourteen of the 27 patients with tuberculosis were recognized as having tuberculosis before being treated for HIV with HAART and were on treatment for tuberculosis.
Cryptococcal meningitis
Immune reconstitution inflammatory syndrome with cryptococcal meningitis was a common cause for admission to the hospital. This occurred in 12 patients (Table 1) . Immune reconstitution inflammatory syndrome associated with cryptococcal meningitis was noted to occur from 2 to 120 days after the initiation of HAART (median, 30 days).
Chronic diarrhea/gastroenteritis
Ten patients were hospitalized with unexplained gastroenteritis (Table 1 ). This number was increased over the 8 patients with gastroenteritis admitted to the hospital before initiation of HAART. The gastroenteritis occurred from 2 to 150 days after beginning HAART with a median of 30 days. One patient on HAART was admitted for gastroenteritis 1 year after beginning HAART. Patients attending the clinic had significant numbers of parasites identified in their stools and this may have accounted for the gastrointestinal disease in some patients although no parasites were noted in the stools of the patients hospitalized with gastroenteritis. Nevertheless, the incidence of parasites in the gastrointestinal tract of HIV-infected patients attending the outpatient clinic was high. For example, of the first 58 stool samples ordered on HIV-infected outpatients with diarrhea, 12 or 21% had parasites in the stool, requiring treatment. Giardia was found in 6 patients; Entamoebae histolytica in 4; Hymenolopis nana in 2; and Ascaris and Enterobius in 1 patient each.
Other Causes of IRIS
Central nervous system toxoplasmosis was seen in 7 patients on HAART (Table 1 ). Presumed bacterial pneumonia occurred in 6 patients and PCP in 5 patients.
Other Causes of Hospitalization in the HAART Group
The majority of the non-IRIS-related hospitalizations occurred for severe anemia requiring transfusion. Eighteen patients were on ZDV-containing regimens and were admitted for transfusion. Six other admissions to the hospital occurred without evidence of an infectious process.
Death from IRIS
Four or 5% of the 74 patients hospitalized with IRIS died during hospitalization. Three patients died with IRIS with cryptococcal meningitis and 1 patient died with gastroenteritis. Of the 74 patients hospitalized with IRIS, 37 (50%) were lost to follow-up; loss to follow-up occurred in 189 of 965 or 20% of patients not hospitalized for IRIS. Because of loss of patients to follow-up, it is conceivable that mortality from IRIS may be much greater than the 5% occurring during hospitalization.
Timing of IRIS
As can be appreciated in Figure 1 , 45 of 74 or 61% of the patients were hospitalized within 1 month of starting HAART. By 3 months of HAART, this number had increased to 60 of 74 or 81% of the patients. By 6 months of HAART, 73 of 74 patients or 99% of the study group had been hospitalized with IRIS. It is commonly believed that the majority of cases of IRIS occur within the first 3 months. 5,6 
Discussion
There is an urgency in resource-poor settings to place appropriate patients on HAART. With shortages of trained personnel, infectious processes may be overlooked at the time patients are started on HAART. This occurs even in resource-rich settings but even severe IRIS is most often successfully addressed. This study was undertaken to determine how often IRIS occurred and the outcome of the disease. Immune reconstitution inflammatory syndrome was a common diagnosis in HIV-infected patients admitted to the hospital after beginning HAART and was fatal in 5% of patients with IRIS. Because so many patients were lost to follow-up, one could not determine whether they died, were transferred to another facility, or simply stopped attending the clinic. Given these limitations to the data, we confined our investigation to hospitalized patients in whom we were able to determine the diagnosis as well as the immediate patient outcome.
The patient population served by this clinic clearly has risk factors for IRIS. Specifically, the patients are all HIV-positive and in patients where CD4 counts were performed, it is apparent that patients were very immunosuppressed. The average CD4 count was 102 + 77 cells/mm 3 and the median CD4 count was 89 cells/mm 3 . The level of immunosuppression before starting HAART (as measured by CD4 count) and the decline in viral load is thought to correlate with the likelihood that IRIS will occur. 1 Viral loads were not performed. Although viral load data is critical for the diagnosis of IRIS where the test is available, such resources were not available for these patients.
Approximately 7% of the patients in this study begun on HAART were eventually hospitalized for a manifestation of IRIS. This indicates how often only the most severe forms of IRIS occur. It is similar to the 8% of patients found during the first year after initiating HAART in a resource-poor setting in Thailand. 7 We could not determine how many patients remained at home with IRIS or may have died of IRIS outside the hospital. These statistics were not obtainable because more than half the patients (50%) with IRIS were lost to follow-up. Of those hospitalized with IRIS, 5% died denoting this is a significant problem. A prospective study of IRIS in Ethiopia was recently published with similar percentages of the common opportunistic infections we noted in our report but with a higher death rate (3/32). 8 The number of adult patients admitted to the hospital with gastroenteritis while on HAART was interesting. In 2 comprehensive reviews of IRIS there is no mention of gastroenteritis as a manifestation of IRIS. 1, 9 Only 1 instance of Isopora belli gastroenteritis/ diarrhea was reported in the only other communication concerning IRIS in Ethiopia. 8 One entry found in PubMed searching for gastroenteritis and IRIS reported that acute appendicitis might be a manifestation of IRIS. 10 We believe that gastroenteritis is a bona fide example of IRIS. Possible pathogens are legion, but would include mycobacteria, cytomegalovirus (CMV), or perhaps parasites. Identifiable parasites were common in the stool samples of the patients as mentioned. Although bacterial cultures were not available, it is possible that some of the patients had bacterial causes of gastroenteritis that went unidentified. The HAART regimens in use in Ethiopia are not commonly associated with gastroenteritis.
An important outcome of this study was finding that patient records were both inadequate and insecure. This will have long-term ramifications for the management and treatment of the patients. The clinic serves a large population of rural Ethiopians over an extensive geographic area. We found that 7% of the charts were missing. Some records may have been taken by patients transferring care to another HIV clinic, but the transfer record sheet did not document this fact. Chart documentation was another problem. For example, prescribed HAART regimens were was not recorded in 112 or 10% of the records reviewed. The clinic is in the process of computerizing its pharmacy records which will rectify part of this problem. Lastly, 15% of the patients did not have a CD4 count recorded, either because it had not been done or had not been recorded.
Large number of patients are served by the clinic and there is an emphasis upon starting medications rapidly. The history and the physical examination performed before initiating HAART were cursory. Therefore, opportunistic infections existing before initiation of HAART were often not discovered. This practice raises the risk that IRIS will occur. Ratnam et al 2 suggest screening before initiating HAART (for example, a chest x-ray) may be needed in selected patients with the most advanced immunosuppression. In 1 study from South Africa, the rate of IRIS was 32% of patients with tuberculosis 11 and it may occur more often in patients with extrapulmonary disease. 12 Tuberculosis was a cause of IRIS in 36% of our cases and in about half of the patients the disease was known to be present before initiation of HAART. Addressing identified opportunistic infections prior to initiating HAART is an important strategy; indeed, 1 report claims that HAART ''unmasks'' tuberculosis. 13 In our study, prescreening chest x-rays would perhaps identify some of the 27 patients later found to have IRIS associated with tuberculosis.
